Picard Medical Faces Securities Fraud Lawsuit
Analysis based on 142 articles · First reported Feb 03, 2026 · Last updated Apr 12, 2026
The market is negatively impacted by the alleged fraudulent activities of Picard Medical, Inc., leading to investor losses and a class action lawsuit. This event highlights the risks of stock promotion schemes and the importance of due diligence for investors.
Rosen Law Firm has reminded investors of the April 13, 2026, lead plaintiff deadline for a class action lawsuit against Picard Medical, Inc. The lawsuit alleges that Picard Medical engaged in a fraudulent stock promotion scheme, involving social media misinformation and impersonated financial professionals, between September 2, 2025, and October 31, 2025. Insiders and/or affiliates are accused of using offshore or nominee accounts to dump shares during a price inflation campaign. The lawsuit claims that Picard Medical's public statements and risk disclosures failed to mention these false rumors and artificial trading activities, making their positive statements materially misleading. Philip Kim and Lawrence Rosen of Rosen Law Firm are leading the efforts to represent affected investors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard